Chattem Chemicals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is DIHYDROCODEINE BITARTRATE USP, with a corresponding US DMF Number 32354.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 22, 2025, and payment made on October 01, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II